The impressive earnings results Netflix posted at market close yesterday resulted in major gains today. Altisource Portfolio Solutions (NASDAQ:ASPS) and Seventy Seven Energy (NYSE:SSE) also ended the day well in the green. In the red this Wednesday are Eldorado Gold Corp. (NYSE:EGO), Intrexon Corp. (NYSE:XON) and Kite Pharma Inc. (NASDAQ:KITE).
David Einhorn Buys Three New Stocks: These Are The Names And Theses (Q3 Letter)
David Einhorn's Greenlight Capital funds returned 5.9% in the third quarter of 2020, compared to a gain of 8.9% for the S&P 500 in the same period. This year has been particularly challenging for value investors. Growth stocks have surged as value has struggled. For Greenlight, one of Wall Street's most established value-focused investment funds, Read More
Netflix soared +17.34% today after posting better-than-expected earnings and strong international growth. The internet streaming service has been one of Carl Icahn’s best investments in recent years, its price more than tripling since he first invested in 2012 (he’s already cashed in quite a bit). Fellow billionaire George Soros initiated a stake in the company in the third quarter of last year.
Altisource Portfolio Solutions hit market close posting a +16.23% gain for the day, though it’s still lost -48.02% over the past month. Today, Leon Cooperman made regulatory filings disclosing an increased stake in the stock.
Chesapeake Energy spinoff Seventy Seven Energy rallied +12.24% today, and yesterday, an issue of its bonds rose +2% against their face value. The stock has tumbled -80.65% since splitting off in June.
Eldorado Gold Plummets on Disappointing Forecast
Eldorado Gold plummeted -20.18% after issuing a disappointing forecast for 2015. Ray Dalio’s Bridgwater Associates picked up a stake in the company in late 2012 and as of the third quarter of 2014 holds 644,000 EGO shares.
Intrexon tumbled -12.32% today, just a day after announcing an underwritten public offering of up to $150 million of its shares in company stocks. As of their most recent 13F filings, both Dan Loeb and David Einhorn have positions in the synthetic biology company.
Kite Pharma ended the day down -9.22%, putting its five-day loss at -20.21%. Despite its recent dip, however, the stock is up +88.31% over the past three months. George Soros has made a nice gain on this one.